The Assessment of Prednisone in Remission (TAPIR) Trial is being administered by the Vasculitis Clinical Research Consortium (VCRC) and is funded through the National Heart Lung and Blood Institute and National Institutes of Health with the purpose of exploring novel methods of conducting clinical trials.
The Vasculitis Foundation is pleased to support The Assessment of
Prednisone in Remission (TAPIR) Trial and encourages patients with
Granulomatosis with polyangiitis (GPA/Wegener's) to participate.
Read More >